Awareness of J&J lawsuits affects the company stocks

Introduction

As J&J is vigorously defending itself in the second ongoing mesothelioma trial allegedly linked to its Talcum Powder product, the company witnessed a dip in its stock value by 5 % earlier this month attributed to the unveiling of documents at the court that revealed the talc powder contained asbestos and other cancer-causing heavy metals.

The giant conglomerate is also facing thousands of ovarian cancer lawsuits filed on behalf of women who allegedly developed ovarian cancer linked to the use of Talcum Powder for feminine hygiene purposes.

Comments

Pesticide Shield Bill Faces Long Odds in Missouri Senate

Categories: General

Legislation aimed at making it harder to sue pesticide manufacturers over cancer claims is facing a critical deadline, with an unusual coalition of opponents striving to stall its progress.

…

Philips Sues CPAP Cleaner SoClean to Share Settlement Costs

Categories: Settlements

Philips has filed a lawsuit against SoClean, a company that manufactures ozone-based cleaning systems…

NJ Pharma Settles: Cash, Narcan for Delaware

Categories: Settlements

Amneal Pharmaceuticals, a New Jersey-based drug manufacturer, has reached a settlement agreement with Delaware and other states over its involvement in the…

Awareness of J&J lawsuits affects the company stocks